Oberwil, Switzerland

Kaspar Zimmerman


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):

Title: Inventor Profile - Kaspar Zimmerman

Introduction

Kaspar Zimmerman is an accomplished inventor based in Oberwil, Switzerland. He is known for his contributions to the field of pharmaceuticals, particularly in the development of innovative compounds that have significant therapeutic potential. With a focus on advancements in drug design, Zimmerman holds a noteworthy patent that reflects his expertise.

Latest Patents

Zimmerman's most recent patent is titled "Acetylene derivatives having MGluR 5 antagonistic activity." This invention encompasses compounds of formula I, whereby n, A, R, R', R'', R, X, and Y are defined within the description. These compounds are recognized for their utility as pharmaceuticals, offering promising avenues for therapeutic applications. His contribution in this area showcases his commitment to enhancing treatment options in the medical field.

Career Highlights

Currently, Kaspar Zimmerman is associated with Novartis AG, a leading global healthcare company. His work at Novartis reflects his dedication to pushing the boundaries of medical research and drug development. The innovative nature of his work is underscored by the successful patent that he holds, positioning him as a key contributor in the pharmaceutical industry.

Collaborations

Throughout his career, Zimmerman has collaborated with talented colleagues, including Fabrizio Gasparini and Yves Auberson. These partnerships have allowed for the exchange of ideas and expertise, furthering advancements in pharmaceutical innovations. The synergy among these professionals exemplifies the collaborative spirit essential for success in research and development.

Conclusion

In summary, inventor Kaspar Zimmerman stands out as a significant figure in the realm of pharmaceuticals, with a patent that demonstrates innovative thinking and dedication to improving health outcomes. His work at Novartis AG, along with collaborations with esteemed colleagues, highlights his valuable contributions to the field, promising advancements that could benefit countless individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…